Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -111,751 | -49,916 | -284,002 | -214,794 | -103,129 |
| Depreciation Amortization | 7,215 | 3,570 | 13,296 | 9,665 | 6,351 |
| Income taxes - deferred | N/A | N/A | -167,305 | -164,585 | 98 |
| Accounts receivable | -6,043 | -1,047 | -7,725 | -4,288 | -2,226 |
| Other Working Capital | -22,045 | -3,935 | -23,997 | -9,614 | -8,996 |
| Other Operating Activity | 26,108 | 1,807 | 256,038 | 242,955 | 16,145 |
| Operating Cash Flow | $-106,516 | $-49,521 | $-213,695 | $-140,661 | $-91,757 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -169,995 | -181,784 | -166,715 | -219,377 | -46,585 |
| PPE Investments | -1,881 | -819 | -4,526 | -3,398 | -2,279 |
| Investing Cash Flow | $-171,876 | $-182,603 | $-171,241 | $-222,775 | $-48,864 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -142 | -71 | -308 | -212 | -142 |
| Common Stock Issued | 305,781 | 298,562 | 259,338 | 251,877 | 1,554 |
| Common Stock Repurchased | -2,027 | -1,912 | -1,596 | -1,067 | -1,003 |
| Other Financing Activity | 0 | 0 | -10,000 | -10,028 | -10,028 |
| Financing Cash Flow | $303,612 | $296,579 | $247,434 | $240,570 | $-9,619 |
| Exchange Rate Effect | -1,016 | 860 | 1,326 | 1,030 | 614 |
| Beginning Cash Position | 51,237 | 51,237 | 187,413 | 187,413 | 187,413 |
| End Cash Position | 75,441 | 116,552 | 51,237 | 65,577 | 37,787 |
| Net Cash Flow | $24,204 | $65,315 | $-136,176 | $-121,836 | $-149,626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -106,516 | -49,521 | -213,695 | -140,661 | -91,757 |
| Capital Expenditure | -1,881 | -819 | -4,526 | -3,398 | -2,279 |
| Free Cash Flow | -108,397 | -50,340 | -218,221 | -144,059 | -94,036 |